nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromhexine—Abdominal pain upper—Cabazitaxel—prostate cancer	0.0149	0.0149	CcSEcCtD
Bromhexine—Angioedema—Estrone—prostate cancer	0.0115	0.0115	CcSEcCtD
Bromhexine—Immune system disorder—Estradiol valerate/Dienogest—prostate cancer	0.0114	0.0114	CcSEcCtD
Bromhexine—Immune system disorder—Degarelix—prostate cancer	0.0108	0.0108	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Abiraterone—prostate cancer	0.0108	0.0108	CcSEcCtD
Bromhexine—Anaphylactic shock—Estrone—prostate cancer	0.0103	0.0103	CcSEcCtD
Bromhexine—Immune system disorder—Cabazitaxel—prostate cancer	0.0102	0.0102	CcSEcCtD
Bromhexine—Skin disorder—Abiraterone—prostate cancer	0.0102	0.0102	CcSEcCtD
Bromhexine—Angioedema—Estradiol valerate/Dienogest—prostate cancer	0.01	0.01	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Flutamide—prostate cancer	0.00985	0.00985	CcSEcCtD
Bromhexine—Skin disorder—Flutamide—prostate cancer	0.00924	0.00924	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Abiraterone—prostate cancer	0.00903	0.00903	CcSEcCtD
Bromhexine—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.00898	0.00898	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Degarelix—prostate cancer	0.00884	0.00884	CcSEcCtD
Bromhexine—Immune system disorder—Bicalutamide—prostate cancer	0.00877	0.00877	CcSEcCtD
Bromhexine—Anaphylactic shock—Degarelix—prostate cancer	0.00853	0.00853	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Cabazitaxel—prostate cancer	0.00833	0.00833	CcSEcCtD
Bromhexine—Skin disorder—Degarelix—prostate cancer	0.00829	0.00829	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Nilutamide—prostate cancer	0.00825	0.00825	CcSEcCtD
Bromhexine—Bronchospasm—Conjugated Estrogens—prostate cancer	0.00822	0.00822	CcSEcCtD
Bromhexine—Urticaria—Estrone—prostate cancer	0.00817	0.00817	CcSEcCtD
Bromhexine—Skin disorder—Cabazitaxel—prostate cancer	0.00781	0.00781	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Estradiol valerate/Dienogest—prostate cancer	0.00775	0.00775	CcSEcCtD
Bromhexine—Angioedema—Bicalutamide—prostate cancer	0.00772	0.00772	CcSEcCtD
Bromhexine—Pruritus—Estramustine—prostate cancer	0.00762	0.00762	CcSEcCtD
Bromhexine—Immune system disorder—Ethinyl Estradiol—prostate cancer	0.00741	0.00741	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Degarelix—prostate cancer	0.00737	0.00737	CcSEcCtD
Bromhexine—Diarrhoea—Estramustine—prostate cancer	0.00737	0.00737	CcSEcCtD
Bromhexine—Pruritus—Estrone—prostate cancer	0.00728	0.00728	CcSEcCtD
Bromhexine—Diarrhoea—Abiraterone—prostate cancer	0.00715	0.00715	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Bicalutamide—prostate cancer	0.00714	0.00714	CcSEcCtD
Bromhexine—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.00713	0.00713	CcSEcCtD
Bromhexine—Abdominal pain upper—Estradiol—prostate cancer	0.00707	0.00707	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.00694	0.00694	CcSEcCtD
Bromhexine—Vomiting—Estramustine—prostate cancer	0.00685	0.00685	CcSEcCtD
Bromhexine—Rash—Estramustine—prostate cancer	0.00679	0.00679	CcSEcCtD
Bromhexine—Dermatitis—Estramustine—prostate cancer	0.00678	0.00678	CcSEcCtD
Bromhexine—Urticaria—Degarelix—prostate cancer	0.00678	0.00678	CcSEcCtD
Bromhexine—Pruritus—Nilutamide—prostate cancer	0.00676	0.00676	CcSEcCtD
Bromhexine—Pruritus—Flutamide—prostate cancer	0.00673	0.00673	CcSEcCtD
Bromhexine—Skin disorder—Bicalutamide—prostate cancer	0.0067	0.0067	CcSEcCtD
Bromhexine—Vomiting—Abiraterone—prostate cancer	0.00665	0.00665	CcSEcCtD
Bromhexine—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.00661	0.00661	CcSEcCtD
Bromhexine—Rash—Abiraterone—prostate cancer	0.00659	0.00659	CcSEcCtD
Bromhexine—Dermatitis—Abiraterone—prostate cancer	0.00659	0.00659	CcSEcCtD
Bromhexine—Abdominal pain upper—Mitoxantrone—prostate cancer	0.00658	0.00658	CcSEcCtD
Bromhexine—Bronchospasm—Estradiol—prostate cancer	0.00658	0.00658	CcSEcCtD
Bromhexine—Vomiting—Estrone—prostate cancer	0.00654	0.00654	CcSEcCtD
Bromhexine—Diarrhoea—Nilutamide—prostate cancer	0.00654	0.00654	CcSEcCtD
Bromhexine—Angioedema—Ethinyl Estradiol—prostate cancer	0.00653	0.00653	CcSEcCtD
Bromhexine—Diarrhoea—Flutamide—prostate cancer	0.00651	0.00651	CcSEcCtD
Bromhexine—Rash—Estrone—prostate cancer	0.00648	0.00648	CcSEcCtD
Bromhexine—Dermatitis—Estrone—prostate cancer	0.00648	0.00648	CcSEcCtD
Bromhexine—Nausea—Estramustine—prostate cancer	0.0064	0.0064	CcSEcCtD
Bromhexine—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00635	0.00635	CcSEcCtD
Bromhexine—Hypersensitivity—Degarelix—prostate cancer	0.00629	0.00629	CcSEcCtD
Bromhexine—Nausea—Estrone—prostate cancer	0.00611	0.00611	CcSEcCtD
Bromhexine—Immune system disorder—Goserelin—prostate cancer	0.0061	0.0061	CcSEcCtD
Bromhexine—Vomiting—Nilutamide—prostate cancer	0.00607	0.00607	CcSEcCtD
Bromhexine—Vomiting—Flutamide—prostate cancer	0.00605	0.00605	CcSEcCtD
Bromhexine—Immune system disorder—Conjugated Estrogens—prostate cancer	0.00604	0.00604	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—prostate cancer	0.00604	0.00604	CcSEcCtD
Bromhexine—Pruritus—Degarelix—prostate cancer	0.00604	0.00604	CcSEcCtD
Bromhexine—Rash—Nilutamide—prostate cancer	0.00602	0.00602	CcSEcCtD
Bromhexine—Dermatitis—Nilutamide—prostate cancer	0.00602	0.00602	CcSEcCtD
Bromhexine—Rash—Flutamide—prostate cancer	0.006	0.006	CcSEcCtD
Bromhexine—Dermatitis—Flutamide—prostate cancer	0.00599	0.00599	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.00595	0.00595	CcSEcCtD
Bromhexine—Hypersensitivity—Cabazitaxel—prostate cancer	0.00592	0.00592	CcSEcCtD
Bromhexine—Diarrhoea—Degarelix—prostate cancer	0.00584	0.00584	CcSEcCtD
Bromhexine—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00571	0.00571	CcSEcCtD
Bromhexine—Nausea—Nilutamide—prostate cancer	0.00567	0.00567	CcSEcCtD
Bromhexine—Skin disorder—Ethinyl Estradiol—prostate cancer	0.00566	0.00566	CcSEcCtD
Bromhexine—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00566	0.00566	CcSEcCtD
Bromhexine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00565	0.00565	CcSEcCtD
Bromhexine—Nausea—Flutamide—prostate cancer	0.00565	0.00565	CcSEcCtD
Bromhexine—Diarrhoea—Cabazitaxel—prostate cancer	0.0055	0.0055	CcSEcCtD
Bromhexine—Urticaria—Bicalutamide—prostate cancer	0.00548	0.00548	CcSEcCtD
Bromhexine—Vomiting—Degarelix—prostate cancer	0.00543	0.00543	CcSEcCtD
Bromhexine—Rash—Degarelix—prostate cancer	0.00538	0.00538	CcSEcCtD
Bromhexine—Dermatitis—Degarelix—prostate cancer	0.00538	0.00538	CcSEcCtD
Bromhexine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00533	0.00533	CcSEcCtD
Bromhexine—Angioedema—Conjugated Estrogens—prostate cancer	0.00532	0.00532	CcSEcCtD
Bromhexine—Vomiting—Cabazitaxel—prostate cancer	0.00511	0.00511	CcSEcCtD
Bromhexine—Bronchospasm—Etoposide—prostate cancer	0.0051	0.0051	CcSEcCtD
Bromhexine—Hypersensitivity—Bicalutamide—prostate cancer	0.00508	0.00508	CcSEcCtD
Bromhexine—Nausea—Degarelix—prostate cancer	0.00507	0.00507	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.00503	0.00503	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.00497	0.00497	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.00492	0.00492	CcSEcCtD
Bromhexine—Pruritus—Bicalutamide—prostate cancer	0.00488	0.00488	CcSEcCtD
Bromhexine—Immune system disorder—Estradiol—prostate cancer	0.00484	0.00484	CcSEcCtD
Bromhexine—Anaphylactic shock—Goserelin—prostate cancer	0.0048	0.0048	CcSEcCtD
Bromhexine—Nausea—Cabazitaxel—prostate cancer	0.00478	0.00478	CcSEcCtD
Bromhexine—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.00475	0.00475	CcSEcCtD
Bromhexine—Diarrhoea—Bicalutamide—prostate cancer	0.00472	0.00472	CcSEcCtD
Bromhexine—Skin disorder—Goserelin—prostate cancer	0.00466	0.00466	CcSEcCtD
Bromhexine—Urticaria—Ethinyl Estradiol—prostate cancer	0.00463	0.00463	CcSEcCtD
Bromhexine—Skin disorder—Conjugated Estrogens—prostate cancer	0.00462	0.00462	CcSEcCtD
Bromhexine—Abdominal pain upper—Docetaxel—prostate cancer	0.00455	0.00455	CcSEcCtD
Bromhexine—Abdominal pain upper—Capecitabine—prostate cancer	0.00441	0.00441	CcSEcCtD
Bromhexine—Vomiting—Bicalutamide—prostate cancer	0.00438	0.00438	CcSEcCtD
Bromhexine—Rash—Bicalutamide—prostate cancer	0.00435	0.00435	CcSEcCtD
Bromhexine—Dermatitis—Bicalutamide—prostate cancer	0.00434	0.00434	CcSEcCtD
Bromhexine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00429	0.00429	CcSEcCtD
Bromhexine—Angioedema—Estradiol—prostate cancer	0.00426	0.00426	CcSEcCtD
Bromhexine—Bronchospasm—Docetaxel—prostate cancer	0.00424	0.00424	CcSEcCtD
Bromhexine—Pruritus—Ethinyl Estradiol—prostate cancer	0.00412	0.00412	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.0041	0.0041	CcSEcCtD
Bromhexine—Bronchospasm—Capecitabine—prostate cancer	0.0041	0.0041	CcSEcCtD
Bromhexine—Nausea—Bicalutamide—prostate cancer	0.0041	0.0041	CcSEcCtD
Bromhexine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00399	0.00399	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.00394	0.00394	CcSEcCtD
Bromhexine—Urticaria—Goserelin—prostate cancer	0.00381	0.00381	CcSEcCtD
Bromhexine—Anaphylactic shock—Estradiol—prostate cancer	0.0038	0.0038	CcSEcCtD
Bromhexine—Urticaria—Conjugated Estrogens—prostate cancer	0.00377	0.00377	CcSEcCtD
Bromhexine—Immune system disorder—Etoposide—prostate cancer	0.00375	0.00375	CcSEcCtD
Bromhexine—Vomiting—Ethinyl Estradiol—prostate cancer	0.00371	0.00371	CcSEcCtD
Bromhexine—Skin disorder—Estradiol—prostate cancer	0.00369	0.00369	CcSEcCtD
Bromhexine—Rash—Ethinyl Estradiol—prostate cancer	0.00368	0.00368	CcSEcCtD
Bromhexine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00367	0.00367	CcSEcCtD
Bromhexine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00354	0.00354	CcSEcCtD
Bromhexine—Hypersensitivity—Goserelin—prostate cancer	0.00353	0.00353	CcSEcCtD
Bromhexine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.0035	0.0035	CcSEcCtD
Bromhexine—Nausea—Ethinyl Estradiol—prostate cancer	0.00346	0.00346	CcSEcCtD
Bromhexine—Skin disorder—Mitoxantrone—prostate cancer	0.00344	0.00344	CcSEcCtD
Bromhexine—Pruritus—Goserelin—prostate cancer	0.00339	0.00339	CcSEcCtD
Bromhexine—Pruritus—Conjugated Estrogens—prostate cancer	0.00336	0.00336	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Estradiol—prostate cancer	0.00328	0.00328	CcSEcCtD
Bromhexine—Diarrhoea—Goserelin—prostate cancer	0.00328	0.00328	CcSEcCtD
Bromhexine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00325	0.00325	CcSEcCtD
Bromhexine—Immune system disorder—Docetaxel—prostate cancer	0.00311	0.00311	CcSEcCtD
Bromhexine—Abdominal pain upper—Epirubicin—prostate cancer	0.00307	0.00307	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.00305	0.00305	CcSEcCtD
Bromhexine—Vomiting—Goserelin—prostate cancer	0.00305	0.00305	CcSEcCtD
Bromhexine—Rash—Goserelin—prostate cancer	0.00302	0.00302	CcSEcCtD
Bromhexine—Dermatitis—Goserelin—prostate cancer	0.00302	0.00302	CcSEcCtD
Bromhexine—Vomiting—Conjugated Estrogens—prostate cancer	0.00302	0.00302	CcSEcCtD
Bromhexine—Urticaria—Estradiol—prostate cancer	0.00302	0.00302	CcSEcCtD
Bromhexine—Immune system disorder—Capecitabine—prostate cancer	0.00302	0.00302	CcSEcCtD
Bromhexine—Rash—Conjugated Estrogens—prostate cancer	0.003	0.003	CcSEcCtD
Bromhexine—Dermatitis—Conjugated Estrogens—prostate cancer	0.00299	0.00299	CcSEcCtD
Bromhexine—Anaphylactic shock—Etoposide—prostate cancer	0.00295	0.00295	CcSEcCtD
Bromhexine—Skin disorder—Etoposide—prostate cancer	0.00286	0.00286	CcSEcCtD
Bromhexine—Nausea—Goserelin—prostate cancer	0.00285	0.00285	CcSEcCtD
Bromhexine—Abdominal pain upper—Doxorubicin—prostate cancer	0.00284	0.00284	CcSEcCtD
Bromhexine—Nausea—Conjugated Estrogens—prostate cancer	0.00282	0.00282	CcSEcCtD
Bromhexine—Urticaria—Mitoxantrone—prostate cancer	0.00282	0.00282	CcSEcCtD
Bromhexine—Hypersensitivity—Estradiol—prostate cancer	0.0028	0.0028	CcSEcCtD
Bromhexine—Pruritus—Estradiol—prostate cancer	0.00269	0.00269	CcSEcCtD
Bromhexine—Immune system disorder—Prednisone—prostate cancer	0.00269	0.00269	CcSEcCtD
Bromhexine—Hypersensitivity—Mitoxantrone—prostate cancer	0.00261	0.00261	CcSEcCtD
Bromhexine—Diarrhoea—Estradiol—prostate cancer	0.0026	0.0026	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Etoposide—prostate cancer	0.00254	0.00254	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.00254	0.00254	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.00246	0.00246	CcSEcCtD
Bromhexine—Anaphylactic shock—Docetaxel—prostate cancer	0.00245	0.00245	CcSEcCtD
Bromhexine—Diarrhoea—Mitoxantrone—prostate cancer	0.00242	0.00242	CcSEcCtD
Bromhexine—Vomiting—Estradiol—prostate cancer	0.00242	0.00242	CcSEcCtD
Bromhexine—Rash—Estradiol—prostate cancer	0.0024	0.0024	CcSEcCtD
Bromhexine—Dermatitis—Estradiol—prostate cancer	0.0024	0.0024	CcSEcCtD
Bromhexine—Skin disorder—Docetaxel—prostate cancer	0.00238	0.00238	CcSEcCtD
Bromhexine—Angioedema—Prednisone—prostate cancer	0.00237	0.00237	CcSEcCtD
Bromhexine—Urticaria—Etoposide—prostate cancer	0.00234	0.00234	CcSEcCtD
Bromhexine—Skin disorder—Capecitabine—prostate cancer	0.0023	0.0023	CcSEcCtD
Bromhexine—Nausea—Estradiol—prostate cancer	0.00226	0.00226	CcSEcCtD
Bromhexine—Vomiting—Mitoxantrone—prostate cancer	0.00225	0.00225	CcSEcCtD
Bromhexine—Rash—Mitoxantrone—prostate cancer	0.00223	0.00223	CcSEcCtD
Bromhexine—Dermatitis—Mitoxantrone—prostate cancer	0.00223	0.00223	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00219	0.00219	CcSEcCtD
Bromhexine—Hypersensitivity—Etoposide—prostate cancer	0.00217	0.00217	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Docetaxel—prostate cancer	0.00211	0.00211	CcSEcCtD
Bromhexine—Anaphylactic shock—Prednisone—prostate cancer	0.00211	0.00211	CcSEcCtD
Bromhexine—Nausea—Mitoxantrone—prostate cancer	0.0021	0.0021	CcSEcCtD
Bromhexine—Immune system disorder—Epirubicin—prostate cancer	0.0021	0.0021	CcSEcCtD
Bromhexine—Pruritus—Etoposide—prostate cancer	0.00209	0.00209	CcSEcCtD
Bromhexine—Skin disorder—Prednisone—prostate cancer	0.00205	0.00205	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00205	0.00205	CcSEcCtD
Bromhexine—Diarrhoea—Etoposide—prostate cancer	0.00202	0.00202	CcSEcCtD
Bromhexine—Immune system disorder—Doxorubicin—prostate cancer	0.00194	0.00194	CcSEcCtD
Bromhexine—Urticaria—Capecitabine—prostate cancer	0.00188	0.00188	CcSEcCtD
Bromhexine—Vomiting—Etoposide—prostate cancer	0.00187	0.00187	CcSEcCtD
Bromhexine—Rash—Etoposide—prostate cancer	0.00186	0.00186	CcSEcCtD
Bromhexine—Dermatitis—Etoposide—prostate cancer	0.00186	0.00186	CcSEcCtD
Bromhexine—Hypersensitivity—Docetaxel—prostate cancer	0.0018	0.0018	CcSEcCtD
Bromhexine—Nausea—Etoposide—prostate cancer	0.00175	0.00175	CcSEcCtD
Bromhexine—Hypersensitivity—Capecitabine—prostate cancer	0.00175	0.00175	CcSEcCtD
Bromhexine—Pruritus—Docetaxel—prostate cancer	0.00173	0.00173	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.00171	0.00171	CcSEcCtD
Bromhexine—Urticaria—Prednisone—prostate cancer	0.00168	0.00168	CcSEcCtD
Bromhexine—Pruritus—Capecitabine—prostate cancer	0.00168	0.00168	CcSEcCtD
Bromhexine—Diarrhoea—Docetaxel—prostate cancer	0.00168	0.00168	CcSEcCtD
Bromhexine—Anaphylactic shock—Epirubicin—prostate cancer	0.00165	0.00165	CcSEcCtD
Bromhexine—Diarrhoea—Capecitabine—prostate cancer	0.00162	0.00162	CcSEcCtD
Bromhexine—Skin disorder—Epirubicin—prostate cancer	0.0016	0.0016	CcSEcCtD
Bromhexine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.00158	0.00158	CcSEcCtD
Bromhexine—Vomiting—Docetaxel—prostate cancer	0.00156	0.00156	CcSEcCtD
Bromhexine—Hypersensitivity—Prednisone—prostate cancer	0.00156	0.00156	CcSEcCtD
Bromhexine—Rash—Docetaxel—prostate cancer	0.00154	0.00154	CcSEcCtD
Bromhexine—Dermatitis—Docetaxel—prostate cancer	0.00154	0.00154	CcSEcCtD
Bromhexine—Anaphylactic shock—Doxorubicin—prostate cancer	0.00153	0.00153	CcSEcCtD
Bromhexine—Vomiting—Capecitabine—prostate cancer	0.00151	0.00151	CcSEcCtD
Bromhexine—Rash—Capecitabine—prostate cancer	0.0015	0.0015	CcSEcCtD
Bromhexine—Pruritus—Prednisone—prostate cancer	0.00149	0.00149	CcSEcCtD
Bromhexine—Dermatitis—Capecitabine—prostate cancer	0.00149	0.00149	CcSEcCtD
Bromhexine—Skin disorder—Doxorubicin—prostate cancer	0.00148	0.00148	CcSEcCtD
Bromhexine—Nausea—Docetaxel—prostate cancer	0.00146	0.00146	CcSEcCtD
Bromhexine—Diarrhoea—Prednisone—prostate cancer	0.00145	0.00145	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Epirubicin—prostate cancer	0.00143	0.00143	CcSEcCtD
Bromhexine—Nausea—Capecitabine—prostate cancer	0.00141	0.00141	CcSEcCtD
Bromhexine—Vomiting—Prednisone—prostate cancer	0.00134	0.00134	CcSEcCtD
Bromhexine—Rash—Prednisone—prostate cancer	0.00133	0.00133	CcSEcCtD
Bromhexine—Dermatitis—Prednisone—prostate cancer	0.00133	0.00133	CcSEcCtD
Bromhexine—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.00132	0.00132	CcSEcCtD
Bromhexine—Urticaria—Epirubicin—prostate cancer	0.00131	0.00131	CcSEcCtD
Bromhexine—Nausea—Prednisone—prostate cancer	0.00125	0.00125	CcSEcCtD
Bromhexine—Hypersensitivity—Epirubicin—prostate cancer	0.00122	0.00122	CcSEcCtD
Bromhexine—Urticaria—Doxorubicin—prostate cancer	0.00121	0.00121	CcSEcCtD
Bromhexine—Pruritus—Epirubicin—prostate cancer	0.00117	0.00117	CcSEcCtD
Bromhexine—Diarrhoea—Epirubicin—prostate cancer	0.00113	0.00113	CcSEcCtD
Bromhexine—Hypersensitivity—Doxorubicin—prostate cancer	0.00113	0.00113	CcSEcCtD
Bromhexine—Pruritus—Doxorubicin—prostate cancer	0.00108	0.00108	CcSEcCtD
Bromhexine—Vomiting—Epirubicin—prostate cancer	0.00105	0.00105	CcSEcCtD
Bromhexine—Diarrhoea—Doxorubicin—prostate cancer	0.00105	0.00105	CcSEcCtD
Bromhexine—Rash—Epirubicin—prostate cancer	0.00104	0.00104	CcSEcCtD
Bromhexine—Dermatitis—Epirubicin—prostate cancer	0.00104	0.00104	CcSEcCtD
Bromhexine—Nausea—Epirubicin—prostate cancer	0.000981	0.000981	CcSEcCtD
Bromhexine—Vomiting—Doxorubicin—prostate cancer	0.000972	0.000972	CcSEcCtD
Bromhexine—Rash—Doxorubicin—prostate cancer	0.000964	0.000964	CcSEcCtD
Bromhexine—Dermatitis—Doxorubicin—prostate cancer	0.000963	0.000963	CcSEcCtD
Bromhexine—Nausea—Doxorubicin—prostate cancer	0.000908	0.000908	CcSEcCtD
